Features of the influence of micronized purified flavonoid fraction on remodeling of the venous wall during hypodynamia in the experiment

Introduction . The issue of protecting venous wall remodeling in individuals with reduced physical activity remains relevant and requires study. Aim . To study the effect of micronized purified flavonoid fraction (MPFF) on venous wall remodeling during hypodynamia in an experiment. Materials and methods . The experiment was performed on 15 sexually mature mongrel male dogs. The 1 st group (control) included 5 dogs, in which the normal anatomy of the medial saphenous vein was studied. In the remaining groups, a model of varicose veins of the lower extremities was created. To create conditions of hypodynamia, walking the dogs was excluded. 5 dogs of the 2 nd group (hypodynamia) did not receive pharmacological support. 5 dogs of the 3 rd group (hypodynamia + MPFF) received MPFF orally with food for 30 days once a day at a dose of 23.5 mg/kg of body weight, equivalent to the daily dose for a human weighing 70 kg. All animals underwent a staged duplex study followed by morphological study of the medial saphenous vein. Results . In both experimental groups, clinical and morphological signs of varicose veins were established. The 2 nd group was characterized by pronounced atrophic processes in the smooth muscle and connective tissue components with disruption of the histoarchitecture, a decrease in wall thickness (p < 0.005), with a significant expansion of the lumen (p < 0.005) and lymphohistiocytic infiltration of the outer shell. The 3 rd group was also characterized by atrophic changes. However, ectasia of the vein lumen was not established in all sections (p < 0.005). First of all, this fact is associated with the preservation of the muscular layer of the vein, probably due to the absence of inflammatory changes in the form oflymphohistiocytic infiltration. Conclusion . The use of MPFF preparations reduced venous wall hypotrophy during hypodynamia in a chronic experiment. This effect requires further study in clinical trials for possible extrapolation to the prevention of varicose disease in risk groups. Lymphohistiocytic infiltration of the outer wall of the vein also requires further study.